Skip to main
University-wide Navigation

As COVID-19 Surges, UK HealthCare’s ICU Recovery Clinic Meets Growing Demand

Brain fog and long-hauler are two terms that many have come to know in recent months due to the ongoing COVID-19 pandemic. The struggles associated with the terms are nothing new for those who work in UK HealthCare’s Intensive Care Unit (ICU) Recovery Clinic.

UK Experts Answer Latest Questions About COVID-19 Vaccines, Omicron

Rebecca Dutch, Ph.D., and Vince Venditto, Ph.D., provide the most up-to-date information regarding COVID-19, vaccines and booster shots to address concerns within the campus community.

UK Part of National Collaboration to Study Long COVID-19

The University of Kentucky is participating in a nationwide study that seeks to understand why some people have prolonged symptoms (long COVID) or develop new or returning symptoms after an acute bout of SARS-CoV-2 infection.

Institute for Rural Journalism, KPA Receive Grant

The “Healthy Together Through Vaccinations” grant from the Kentucky Association of Health Plans (KAHP) aims to increase vaccine acceptance in the state.

'Behind The Blue': COVID-19 Update with Rebecca Dutch - 12/9/21

Dr. Dutch returns to the ‘Behind the Blue’ podcast to discuss a wide range of pandemic topics including the Omicron variant, what it means for testing and vaccines, and best practices for the University community.

'UK at the Half': Meet UK Vice President for Research Lisa Cassis

For this “UK at the Half,” Lisa Cassis, vice president for research at the University of Kentucky, shares how leaders across campus came together to find a path forward for research during the COVID-19 pandemic.

UK-led Project Fosters Stronger, Connected Local Food Systems

UK researchers studied pandemic-related impacts to food systems including changes in consumer purchasing behaviors, pandemic responses of different food system sectors, innovations and agency support.

UK to Enroll Additional Children in Moderna Vaccine Trial

The University of Kentucky is a site for KidCOVE, a national trial by Moderna to test the safety and effectiveness of its COVID-19 vaccine in children. The vaccine may protect young children 6 months to those under 12 years of age if they come into contact with the SARS-CoV-2 virus. 

Study Finds Americans Value More Options When it Comes to COVID-19 Testing

Researchers found that most Americans were willing to take a COVID-19 test and valued having options when it came to how, when and where they were tested.

‘Truly Remarkable’: Center for Muscle Biology Lives Up to Challenge During COVID-19

In January 2021, the Center for Muscle Biology (CMB) officially transferred from the UK College of Medicine to become a part of the UK College of Health Sciences.

Filter News